Anti-psychotics Flashcards
Clozapine is atypical (2nd generation) drug that is a core anti-psychotic drug. It is generally used as a last line drug treatment for psychosis, when up to 2 other drugs, one of which must have been an atypical drug have already been tried. What is the mechanism of action of Clozapine?
- antagonist for dopamine receptors
- serotonin 5HT2A antagonist
Clozapine is atypical (2nd generation) drug that is a core anti-psychotic drug. It is generally used as a last line drug treatment for psychosis, when up to 2 other drugs have already been tried. Clozapine has 2 mechanisms:
1 - antagonist for dopamine receptors
2 - serotonin 5HT2A antagonist
Why is the a dopamine antagonist good for treating psychosis?
- able to inhibit where dopamine levels are high such as in mesolimbic system that causes positive symptoms
Clozapine is atypical (2nd generation) drug that is a core anti-psychotic drug. It is generally used as a last line drug treatment for psychosis, when up to 2 other drugs have already been tried. Clozapine has 2 mechanisms:
1 - antagonist for dopamine receptors
2 - serotonin 5HT2A antagonist
Why is the antagonist serotonin 5HT2A receptors good for treating psychosis?
- clozapine is a dopamine receptor antagonist, and when it binds it increases dopamine levels
- but in other parts of the brain antagonist of serotonin 5HT2A receptors causes an increase in dopamine, which is good for negative symptoms and the nigrostriatal pathway
Clozapine is atypical (2nd generation) drug that is a core anti-psychotic drug. It is generally used as a last line drug treatment for psychosis, when up to 2 other drugs, one of which must have been an atypical drug have already been tried. Clozapine is an effective anti-psychotic, by acting as an antagonist for dopamine and serotonin 5HT2A receptors, but there are 2 serious adverse events that it can cause, what are they?
- constipation, which can ultimately kill patients
- neutropenia (low neutrophils)
Aripiprazole is a core anti-psychotic drug that is first line treatment for psychosis. What is the mechanism of action of Aripiprazole?
- partial agonist of dopaminergic receptors
- antagonist of 5HT2A serotonin receptors
Aripiprazole is a core anti-psychotic drug that is first line treatment for psychosis. It has 2 mechanisms of action:
1 - partial agonist of dopaminergic receptors
2 - antagonist of 5HT2A serotonin receptors
Why is this combination of mechanisms a good treatment option for psychosis?
- antagonist of 5HT2A serotonin receptors causes increased dopamine release
- partial agonist of dopaminergic receptors controls how much dopamine binds post-synaptically (not too much or too little, so good for all round effects of psychosis)
Aripiprazole is a core anti-psychotic drug that is first line treatment for psychosis. It has 2 mechanisms of action:
1 - partial agonist of dopaminergic receptors
2 - antagonist of 5HT2A serotonin receptors
When would this drug generally be prescribed?
- first line for someone who has never had a psychotic episode
Chlorpromazine is a member of the typical (1st generation) anti-psychotic medications. What is the mechanism of action for this drug?
- dopamine antagonist of post-synapse
- good for positive psychotic episodes
Haloperidol is a typical (1st generation) anti-psychotic medication. What is its mechanism of action?
- dopamine antagonist of post-synapse
- good for positive psychotic episodes
Risperidone is an atypical (2nd generation) anti-psychotic medication. What is its mechanism of action?
1 - antagonist for dopamine receptors
2 - serotonin 5HT2A antagonist
Risperidone is an atypical (2nd generation) anti-psychotic medication. Risperidone has 2 mechanisms:
1 - antagonist for dopamine receptors
2 - serotonin 5HT2A antagonist
Why is the antagonist of serotonin 5HT2A receptors and dopamine receptors good for treating psychosis?
- inhibits dopamine receptors where dopamine is already high, that may cause positive symptoms
- increase dopamine release by inhibiting serotonin 5HT2A receptors, so good for negative symptoms and nigrostriatal pathway where dopamine may be low